Matarin Capital Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-3,096
Closed -$348K 327
2018
Q1
$348K Hold
3,096
0.03% 265
2017
Q4
$458K Hold
3,096
0.04% 255
2017
Q3
$363K Hold
3,096
0.03% 255
2017
Q2
$402K Hold
3,096
0.04% 233
2017
Q1
$419K Hold
3,096
0.04% 232
2016
Q4
$444K Hold
3,096
0.05% 205
2016
Q3
$366K Hold
3,096
0.04% 204
2016
Q2
$328K Sell
3,096
-26,206
-89% -$2.92M 0.04% 214
2016
Q1
$3.27M Buy
29,302
+2,776
+10% +$351K 0.46% 95
2015
Q4
$4.15M Buy
26,526
+3,136
+13% +$457K 0.62% 73
2015
Q3
$3.07M Buy
23,390
+5,806
+33% +$931K 0.63% 71
2015
Q2
$3.06M Buy
17,584
+832
+5% +$150K 0.88% 32
2015
Q1
$2.89M Buy
16,752
+921
+6% +$140K 0.88% 28
2014
Q4
$2.05M Sell
15,831
-6,516
-29% -$840K 0.9% 36
2014
Q3
$2.87M Sell
22,347
-418
-2% -$43.1K 1.32% 4
2014
Q2
$2.01M Buy
22,765
+3,701
+19% +$356K 0.9% 37
2014
Q1
$1.79M Sell
19,064
-2,531
-12% -$259K 1.06% 23
2013
Q4
$2.44M Buy
21,595
+6,305
+41% +$569K 1.5% 9
2013
Q3
$1.21M Buy
15,290
+2,531
+20% +$185K 1.01% 28
2013
Q2
$840K Buy
+12,759
New +$822K 0.85% 41

Other funds holding UTHR